{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:27:23Z","timestamp":1770668843223,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SD2322N"],"award-info":[{"award-number":["1SD2322N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00204-025-04220-y","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:16:35Z","timestamp":1760627795000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Method validation for quantification of five antineoplastic agents in urine using UPLC\u2013ESI\u2013MS\/MS"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2322-0941","authenticated-orcid":false,"given":"Eline","family":"Verscheure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Vandervoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Deruyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Poels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manosij","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Vanoirbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lode","family":"Godderis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"4220_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijheh.2017.03.005","volume":"220","author":"A B\u00f6hlandt","year":"2017","unstructured":"B\u00f6hlandt A, Sverdel Y, Schierl R (2017) Antineoplastic drug residues inside homes of chemotherapy patients. Int J Hyg Environ Health 220:757\u2013765. https:\/\/doi.org\/10.1016\/j.ijheh.2017.03.005","journal-title":"Int J Hyg Environ Health"},{"key":"4220_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1078155216637217","volume":"23","author":"Y Cass","year":"2017","unstructured":"Cass Y, Connor TH, Tabachnik A (2017) Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home setting. J Oncol Pharm Pract 23:350\u2013378. https:\/\/doi.org\/10.1177\/1078155216637217","journal-title":"J Oncol Pharm Pract"},{"key":"4220_CR3","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1039\/c8an00479j","volume":"143","author":"A Dhersin","year":"2018","unstructured":"Dhersin A, Atg\u00e9 B, Martinez B et al (2018) Biomonitoring of occupational exposure to 5-FU by assaying \u03b1-fluoro-\u03b2-alanine in urine with a highly sensitive UHPLC-MS\/MS method. Analyst 143:4110\u20134117. https:\/\/doi.org\/10.1039\/c8an00479j","journal-title":"Analyst"},{"key":"4220_CR4","doi-asserted-by":"publisher","first-page":"26810","DOI":"10.1007\/S11356-021-17607-Y","volume":"29","author":"L Dole\u017ealov\u00e1","year":"2022","unstructured":"Dole\u017ealov\u00e1 L, Bl\u00e1hov\u00e1 L, Kuta J et al (2022) Levels and risks of surface contamination by thirteen antineoplastic drugs in the Czech and Slovak hospitals and pharmacies. Environ Sci Pollut Res Int 29:26810\u201326819. https:\/\/doi.org\/10.1007\/S11356-021-17607-Y","journal-title":"Environ Sci Pollut Res Int"},{"key":"4220_CR5","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1124\/DMD.110.032326","volume":"38","author":"A Gong","year":"2010","unstructured":"Gong A, Chen X, Deng P, Zhong D (2010) Metabolism of flumatinib, a novel antineoplastic tyrosine kinase inhibitor, in chronic myelogenous leukemia patients. Drug Metab Dispos 38:1328\u20131340. https:\/\/doi.org\/10.1124\/DMD.110.032326","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"4220_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3892\/OL.2016.4780","volume":"12","author":"P Herviou","year":"2016","unstructured":"Herviou P, Thivat E, Richard D et al (2016) Therapeutic drug monitoring and tyrosine kinase inhibitors. Oncol Lett 12(2):1223\u20131232. https:\/\/doi.org\/10.3892\/OL.2016.4780","journal-title":"Oncol Lett"},{"key":"4220_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/1097-0142(19840515)","volume":"53","author":"SC Hopkins","year":"1984","unstructured":"Hopkins SC, Buice G, Matheny R Jr, Soloway MS (1984) The stability and antitumor activity of recycled (lntravesical) mitomycin C. Cancer 53:10. https:\/\/doi.org\/10.1002\/1097-0142(19840515)","journal-title":"Cancer"},{"key":"4220_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1515\/prolas-2016-0049","volume":"70","author":"K Ivanova","year":"2016","unstructured":"Ivanova K, Avota M (2016) Antineoplastic drugs: occupational exposure and side effects. Proc Latv Acad Sci 70:325\u2013329. https:\/\/doi.org\/10.1515\/prolas-2016-0049","journal-title":"Proc Latv Acad Sci"},{"key":"4220_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0378-4347(00)81243-8","volume":"164","author":"A Kono","year":"1979","unstructured":"Kono A, Hara Y, Eguchi S et al (1979) Determination of mitomycin C in biomedical specimens by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 164:404\u2013406. https:\/\/doi.org\/10.1016\/S0378-4347(00)81243-8","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"4220_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/10826076.2018.1522593","volume":"41","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Van Tiggel D, Sugarbaker P et al (2018) A validated high performance liquid chromatography \u2013 diode array detector method for the quantification of mitomycin C in plasma, peritoneal fluid and urine. J Liq Chromatogr Relat Technol 41:839\u2013848. https:\/\/doi.org\/10.1080\/10826076.2018.1522593","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"4220_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8434204","volume":"2021","author":"S Liu","year":"2021","unstructured":"Liu S, Yu Z (2021) A study of the identification, fragmentation mode and metabolic pathways of Imatinib in rats using UHPLC-Q-TOF-MS\/MS. J Anal Methods Chem 2021:8434204. https:\/\/doi.org\/10.1155\/2021\/8434204","journal-title":"J Anal Methods Chem"},{"key":"4220_CR12","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1002\/NOP2.1853","volume":"10","author":"S Liu","year":"2023","unstructured":"Liu S, Huang Y, Huang H et al (2023) Influence of occupational exposure to antineoplastic agents on adverse pregnancy outcomes among nurses: a meta-analysis. Nurs Open 10:5827\u20135837. https:\/\/doi.org\/10.1002\/NOP2.1853","journal-title":"Nurs Open"},{"key":"4220_CR13","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/AC020361S","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS. Anal Chem 75:3019\u20133030. https:\/\/doi.org\/10.1021\/AC020361S","journal-title":"Anal Chem"},{"key":"4220_CR14","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jchromb.2010.02.011","volume":"878","author":"S Ndaw","year":"2010","unstructured":"Ndaw S, Denis F, Marsan P et al (2010) Biological monitoring of occupational exposure to 5-fluorouracil: urinary \u03b1-fluoro-\u03b2-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel. J Chromatogr B Analyt Technol Biomed Life Sci 878:2630\u20132634. https:\/\/doi.org\/10.1016\/j.jchromb.2010.02.011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4220_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJHEH.2024.114402","volume":"260","author":"Y Noda","year":"2024","unstructured":"Noda Y, Koga Y, Yamamura K et al (2024) Cyclophosphamide exposure factors in family caregivers for pediatric cancer patients. Int J Hyg Environ Health 260:114402. https:\/\/doi.org\/10.1016\/J.IJHEH.2024.114402","journal-title":"Int J Hyg Environ Health"},{"key":"4220_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.TOXLET.2024.11.012","volume":"403","author":"MF Portilha-Cunha","year":"2025","unstructured":"Portilha-Cunha MF, Alves A, Ribeiro ARL et al (2025) Development and validation of a multicompound LLE\u2013LC\u2013MS\/MS method for biomonitoring of hazardous medicinal products in urine of exposed workers. Toxicol Lett 403:40\u201349. https:\/\/doi.org\/10.1016\/J.TOXLET.2024.11.012","journal-title":"Toxicol Lett"},{"key":"4220_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00204-023-03481-9","volume":"97","author":"D Vanneste","year":"2023","unstructured":"Vanneste D, Verscheure E, Srinivasan AN et al (2023) Systematic review of genotoxicity induced by occupational exposure to antineoplastic drugs. Arch Toxicol 97:1453\u20131517. https:\/\/doi.org\/10.1007\/s00204-023-03481-9","journal-title":"Arch Toxicol"},{"key":"4220_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCHROMB.2022.123331","volume":"1205","author":"E Verscheure","year":"2022","unstructured":"Verscheure E, Creta M, Vanneste D et al (2022) Quantification of three antineoplastic agents in urine using the UniSpray ionisation source. J Chromatogr B Analyt Technol Biomed Life Sci 1205:123331. https:\/\/doi.org\/10.1016\/J.JCHROMB.2022.123331","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4220_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/S00204-024-03900-5","volume":"99","author":"E Verscheure","year":"2024","unstructured":"Verscheure E, Struys I, Creta M et al (2024) Development and validation of an UPLC-ESI-MS\/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure. Arch Toxicol 99:259\u2013270. https:\/\/doi.org\/10.1007\/S00204-024-03900-5","journal-title":"Arch Toxicol"},{"key":"4220_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/J.ACA.2024.343492","volume":"1336","author":"E Verscheure","year":"2025","unstructured":"Verscheure E, Creta M, Poels K et al (2025) Quantification of five antineoplastic agents in swab samples using UPLC-ESI-MS\/MS: method development and validation. Anal Chim Acta 1336:343492. https:\/\/doi.org\/10.1016\/J.ACA.2024.343492","journal-title":"Anal Chim Acta"},{"key":"4220_CR21","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00420-021-01706-x","volume":"94","author":"A Villa","year":"2021","unstructured":"Villa A, Molimard M, Sakr D et al (2021) Nurses\u2019 internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study. Int Arch Occup Environ Health 94:1839\u20131850. https:\/\/doi.org\/10.1007\/s00420-021-01706-x","journal-title":"Int Arch Occup Environ Health"},{"key":"4220_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1078155212459667","volume":"19","author":"M Yuki","year":"2013","unstructured":"Yuki M, Sekine S, Takase K et al (2013) Exposure of family members to antineoplastic drugs via excreta of treated cancer patients. J Oncol Pharm Pract 19:208\u2013217. https:\/\/doi.org\/10.1177\/1078155212459667","journal-title":"J Oncol Pharm Pract"},{"key":"4220_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1188\/15.ONF.42-06AP","volume":"42","author":"M Yuki","year":"2015","unstructured":"Yuki M, Ishida T, Sekine S (2015) Secondary exposure of family members to cyclophosphamide after chemotherapy of outpatients with cancer: a pilot study. Oncol Nurs Forum 42:665\u2013671. https:\/\/doi.org\/10.1188\/15.ONF.42-06AP","journal-title":"Oncol Nurs Forum"},{"key":"4220_CR24","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/annonc\/mdx668","volume":"28","author":"M Yuki","year":"2017","unstructured":"Yuki M, Miyake A, Hirayama K et al (2017) Family exposure to cyclophosphamide during outpatient treatment. Ann Oncol 28:2017. https:\/\/doi.org\/10.1093\/annonc\/mdx668","journal-title":"Ann Oncol"},{"key":"4220_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ajim.22553","volume":"59","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zheng Q, Lv Y et al (2016) Evaluation of adverse health risks associated with antineoplastic drug exposure in nurses at two Chinese hospitals: the effects of implementing a pharmacy intravenous admixture service. Am J Ind Med 59:264\u2013273. https:\/\/doi.org\/10.1002\/ajim.22553","journal-title":"Am J Ind Med"},{"key":"4220_CR26","unstructured":"Agents Classified by the IARC Monographs, Volumes 1\u2013135\u2014IARC Monographs on the Identification of Carcinogenic Hazards to Humans. https:\/\/monographs.iarc.who.int\/agents-classified-by-the-iarc\/. Accessed 19 Jun 2024"},{"key":"4220_CR27","unstructured":"EMA (2022) ICH guideline M10 on bioanalytical method validation and study sample analysis. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. Accessed 3 Sep 2025"},{"key":"4220_CR28","unstructured":"NCI (2024) Cancer statistics. https:\/\/www.cancer.gov\/about-cancer\/understanding\/statistics. Accessed 10 Jan 2025"},{"key":"4220_CR29","unstructured":"Waters Sep-Pak Cartridges and Plates | Enhanced Reader. https:\/\/help.waters.com\/content\/dam\/waters\/fr\/support\/usermanuals\/2008\/WAT011188\/wat011188.pdf. Accessed 16 Dec 2024"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04220-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04220-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04220-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:31:17Z","timestamp":1770618677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04220-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4220"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04220-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee Research UZ\/KU Leuven (S65895).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}